AI assistant
Sending…
Health Catalyst, Inc. — Director's Dealing 2021
Feb 17, 2021
33681_dirs_2021-02-16_c20ad3f7-3b96-439b-8310-d37e91f3e362.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2020-12-31
Reporting Person: KANE JOHN A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-29 | Common Stock | G | 6000.00 | $0.00 | Disposed | 84466.00 | Direct |
Footnotes
F1: The shares reported in this transaction represent a bona-fide charitable gift to a Donor Advised Fund.
More from Health Catalyst, Inc.
M&A Activity
2026
Jun 4
Proxy Solicitation & Information Statement
2026
Jun 3
Proxy Solicitation & Information Statement
2026
Jun 3
Interim / Quarterly Report
2026
May 11
Board/Management Information
2026
Apr 27
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27